We are thrilled to announce PrescribeDNA as the recipient of the prestigious Best Genetic-Based Brain Health Program in the United States of 2026 award. This remarkable achievement is a testament to their groundbreaking approach to combating cognitive decline and their unwavering commitment to improving brain health. As awarded by Best of Best Review, PrescribeDNA has set a new standard for personalized health strategies, leveraging DNA and specialized biomarkers to “defeat the cognitive enemies” such as Alzheimer’s, dementia, and cognitive decline.

A Unique Approach to Cognitive Health

What makes PrescribeDNA truly stand out in the field of brain health is their innovative and personalized approach. Dr. Alissa Huhn, a board-certified psychiatric pharmacist, nutritional genetics expert, and certified pharmacogenomics consultant, leads the program with a passion that’s deeply personal. As a carrier of the Alzheimer’s risk gene (APOE4), Dr. Huhn’s vested interest in defeating cognitive decline drives her to find cutting-edge solutions that can significantly alter the trajectory of brain health.

This personal connection fuels the program’s mission to provide patients with the best chance against cognitive decline, using data-driven strategies to customize interventions and preventative approaches.

Why Cognitive Decline is Not a Necessary Stage of Aging

PrescribeDNA’s approach challenges the traditional view that cognitive decline is an inevitable part of aging. Dr. Huhn advocates strongly that medication alone will not always prevent decline and, in some cases, may not address underlying root causes.

Instead, she emphasizes the importance of understanding the root contributors to brain health risks. With the ability to test and analyze individual DNA and biomarkers, PrescribeDNA offers a scientific and tailored method to correct cognitive vulnerabilities before they lead to decline. The results are a more proactive, customized, and hopeful approach to brain health that empowers individuals to take control of their cognitive well-being.

What Sets PrescribeDNA Apart

PrescribeDNA is not just another brain health program, it is a leader in the genetic-based health space. The program’s unique combination of expertise in psychiatric pharmacy, nutritional genetics, and pharmacogenomics allows them to provide services and solutions that are highly specialized and difficult to replicate.

Dr. Huhn’s personal experience with the Alzheimer’s risk gene (APOE4) gives her a profound empathy and understanding of the individuals she works with, which fuels her drive to offer more precise, personalized strategies for cognitive wellness.

This level of specialization and care makes PrescribeDNA an invaluable resource for those looking for tailored, scientifically backed approaches to maintain and improve brain health. With a focus on identifying and addressing cognitive vulnerabilities through a combination of lifestyle interventions, targeted nutrition, and early detection strategies, PrescribeDNA is helping to redefine the future of cognitive wellness.

A Community-Driven Approach to Prevention

In addition to their personalized care, PrescribeDNA also fosters a sense of community among participants and supporters. Through their Facebook group, MindProtectRx Community, Dr. Huhn and the PrescribeDNA team provide ongoing support, education, and connection for individuals looking to protect their brain health.

This sense of community encourages participants to share experiences, ask questions, and stay informed on the latest developments in cognitive health. Dr. Alissa Huhn’s expertise, combined with the program’s commitment to empowering individuals to take control of their brain health, has set a new standard in the field of cognitive wellness.

For anyone seeking to protect their brain health, PrescribeDNA offers guidance, answers, and a clear path forward.

To learn more about PrescribeDNA and their revolutionary approach to brain health, visit their website at www.PrescribeDNA.com.